Research Article
Dextran-Polyacrylamide as Matrices for Creation of Anticancer Nanocomposite
Figure 6
Histograms of distribution of U937 cells in content of DNA with the influence of cisplatin in solution or in conjunction with dextran containing nanoparticles: (a) control; (b) cisplatin solution of 3 μmol/L; (c) nanocontainers loaded with cytotoxic chemotherapy drugs cisplatin, 3 μmol/L.
(a) |
(b) |
(c) |